多発性骨髄腫治療薬市場は、2023年から2028年にかけて79億4,470万米ドル成長すると予測されており、予測期間中に6.78%のCAGRで加速すると予測されています。このレポートは、全体的な分析、市場規模と予測、傾向、成長ドライバー、課題、および約25のベンダーをカバーするベンダー分析を提供します。
このレポートは、現在の市場シナリオ、最新の傾向と推進力、および全体的な市場環境に関する最新の分析を提供します。市場は、多発性骨髄腫の罹患率の増加、生物学的療法に対する需要の高まり、および強力な採用率によって牽引されています。
この調査は、ナノ医療プラットフォームの出現が、今後数年間の多発性骨髄腫治療薬市場の成長を促進する主な理由の1つであることを特定しています。また、マイクロRNA治療薬の出現と発展途上国における急速な成長の可能性により、市場での大きな需要が見込まれるでしょう。
また、本レポートには、市場の成長に影響を与える今後の傾向と課題に関する情報が含まれています。これは、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。
この調査は、業界の主要参加者からの意見を含む一次情報と二次情報を客観的に組み合わせて実施されました。このレポートには、主要ベンダーの分析に加えて、包括的な市場とベンダーの状況が含まれています。
このレポートは、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析による複数のソースからのデータの調査、合成、合計により、市場の詳細な全体像を提示します。業界の主要な影響力を持つ企業を特定することで、さまざまな市場の側面を示します。提示されたデータは包括的で信頼性が高く、一次および二次の両方にわたる広範な研究の結果です。市場調査レポートは、正確な市場の成長を予測するための定性的および定量的調査を使用した、完全な競争状況と詳細なベンダー選択方法論および分析を提供します。
目次
Table of Contents
1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Therapy
Executive Summary - Chart on Market Segmentation by Distribution Channel
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Market Landscape
2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis
3 Market Sizing
3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ million)
Data Table on Global - Market size and forecast 2023-2028 ($ million)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global Multiple Myeloma Drugs Market 2018 - 2022
Historic Market Size - Data Table on Global Multiple Myeloma Drugs Market 2018 - 2022 ($ million)
4.2 Therapy segment analysis 2018 - 2022
Historic Market Size - Therapy Segment 2018 - 2022 ($ million)
4.3 Distribution Channel segment analysis 2018 - 2022
Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
4.4 Geography segment analysis 2018 - 2022
Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country segment analysis 2018 - 2022
Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Therapy
6.1 Market segments
Chart on Therapy - Market share 2023-2028 (%)
Data Table on Therapy - Market share 2023-2028 (%)
6.2 Comparison by Therapy
Chart on Comparison by Therapy
Data Table on Comparison by Therapy
6.3 Targeted therapy - Market size and forecast 2023-2028
Chart on Targeted therapy - Market size and forecast 2023-2028 ($ million)
Data Table on Targeted therapy - Market size and forecast 2023-2028 ($ million)
Chart on Targeted therapy - Year-over-year growth 2023-2028 (%)
Data Table on Targeted therapy - Year-over-year growth 2023-2028 (%)
6.4 Biologic therapy - Market size and forecast 2023-2028
Chart on Biologic therapy - Market size and forecast 2023-2028 ($ million)
Data Table on Biologic therapy - Market size and forecast 2023-2028 ($ million)
Chart on Biologic therapy - Year-over-year growth 2023-2028 (%)
Data Table on Biologic therapy - Year-over-year growth 2023-2028 (%)
6.5 Chemotherapy - Market size and forecast 2023-2028
Chart on Chemotherapy - Market size and forecast 2023-2028 ($ million)
Data Table on Chemotherapy - Market size and forecast 2023-2028 ($ million)
Chart on Chemotherapy - Year-over-year growth 2023-2028 (%)
Data Table on Chemotherapy - Year-over-year growth 2023-2028 (%)
6.6 Others - Market size and forecast 2023-2028
Chart on Others - Market size and forecast 2023-2028 ($ million)
Data Table on Others - Market size and forecast 2023-2028 ($ million)
Chart on Others - Year-over-year growth 2023-2028 (%)
Data Table on Others - Year-over-year growth 2023-2028 (%)
6.7 Market opportunity by Therapy
Market opportunity by Therapy ($ million)
Data Table on Market opportunity by Therapy ($ million)
7 Market Segmentation by Distribution Channel
7.1 Market segments
Chart on Distribution Channel - Market share 2023-2028 (%)
Data Table on Distribution Channel - Market share 2023-2028 (%)
7.2 Comparison by Distribution Channel
Chart on Comparison by Distribution Channel
Data Table on Comparison by Distribution Channel
7.3 Hospital pharmacy - Market size and forecast 2023-2028
Chart on Hospital pharmacy - Market size and forecast 2023-2028 ($ million)
Data Table on Hospital pharmacy - Market size and forecast 2023-2028 ($ million)
Chart on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
Data Table on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
7.4 Retail pharmacy - Market size and forecast 2023-2028
Chart on Retail pharmacy - Market size and forecast 2023-2028 ($ million)
Data Table on Retail pharmacy - Market size and forecast 2023-2028 ($ million)
Chart on Retail pharmacy - Year-over-year growth 2023-2028 (%)
Data Table on Retail pharmacy - Year-over-year growth 2023-2028 (%)
7.5 E-pharmacy - Market size and forecast 2023-2028
Chart on E-pharmacy - Market size and forecast 2023-2028 ($ million)
Data Table on E-pharmacy - Market size and forecast 2023-2028 ($ million)
Chart on E-pharmacy - Year-over-year growth 2023-2028 (%)
Data Table on E-pharmacy - Year-over-year growth 2023-2028 (%)
7.6 Market opportunity by Distribution Channel
Market opportunity by Distribution Channel ($ million)
Data Table on Market opportunity by Distribution Channel ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2023-2028 (%)
Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Chart on North America - Market size and forecast 2023-2028 ($ million)
Data Table on North America - Market size and forecast 2023-2028 ($ million)
Chart on North America - Year-over-year growth 2023-2028 (%)
Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Chart on Europe - Market size and forecast 2023-2028 ($ million)
Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Chart on Europe - Year-over-year growth 2023-2028 (%)
Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Chart on Asia - Market size and forecast 2023-2028 ($ million)
Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Chart on Asia - Year-over-year growth 2023-2028 (%)
Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ million)
Data Table on US - Market size and forecast 2023-2028 ($ million)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Germany - Market size and forecast 2023-2028
Chart on Germany - Market size and forecast 2023-2028 ($ million)
Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Chart on Germany - Year-over-year growth 2023-2028 (%)
Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.9 China - Market size and forecast 2023-2028
Chart on China - Market size and forecast 2023-2028 ($ million)
Data Table on China - Market size and forecast 2023-2028 ($ million)
Chart on China - Year-over-year growth 2023-2028 (%)
Data Table on China - Year-over-year growth 2023-2028 (%)
9.10 Canada - Market size and forecast 2023-2028
Chart on Canada - Market size and forecast 2023-2028 ($ million)
Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Chart on Canada - Year-over-year growth 2023-2028 (%)
Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.11 UK - Market size and forecast 2023-2028
Chart on UK - Market size and forecast 2023-2028 ($ million)
Data Table on UK - Market size and forecast 2023-2028 ($ million)
Chart on UK - Year-over-year growth 2023-2028 (%)
Data Table on UK - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Opportunity/Restraints
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
10.4 Market opportunities/restraints
11 Competitive Landscape
11.1 Overview
11.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
11.3 Landscape disruption
Overview on factors of disruption
11.4 Industry risks
Impact of key risks on business
12 Competitive Analysis
12.1 Companies profiled
Companies covered
12.2 Market positioning of companies
Matrix on companies position and classification
12.3 Abbott Laboratories
Abbott Laboratories - Overview
Abbott Laboratories - Business segments
Abbott Laboratories - Key news
Abbott Laboratories - Key offerings
Abbott Laboratories - Segment focus
12.4 AbbVie Inc.
AbbVie Inc. - Overview
AbbVie Inc. - Product / Service
AbbVie Inc. - Key news
AbbVie Inc. - Key offerings
12.5 Amgen Inc.
Amgen Inc. - Overview
Amgen Inc. - Product / Service
Amgen Inc. - Key news
Amgen Inc. - Key offerings
12.6 Bristol Myers Squibb Co.
Bristol Myers Squibb Co. - Overview
Bristol Myers Squibb Co. - Product / Service
Bristol Myers Squibb Co. - Key news
Bristol Myers Squibb Co. - Key offerings
12.7 Daiichi Sankyo Co. Ltd.
Daiichi Sankyo Co. Ltd. - Overview
Daiichi Sankyo Co. Ltd. - Product / Service
Daiichi Sankyo Co. Ltd. - Key news
Daiichi Sankyo Co. Ltd. - Key offerings
12.8 F. Hoffmann La Roche Ltd.
F. Hoffmann La Roche Ltd. - Overview
F. Hoffmann La Roche Ltd. - Business segments
F. Hoffmann La Roche Ltd. - Key news
F. Hoffmann La Roche Ltd. - Key offerings
F. Hoffmann La Roche Ltd. - Segment focus
12.9 GlaxoSmithKline Plc
GlaxoSmithKline Plc - Overview
GlaxoSmithKline Plc - Business segments
GlaxoSmithKline Plc - Key news
GlaxoSmithKline Plc - Key offerings
GlaxoSmithKline Plc - Segment focus
12.10 Johnson and Johnson Services Inc.
Johnson and Johnson Services Inc. - Overview
Johnson and Johnson Services Inc. - Business segments
Johnson and Johnson Services Inc. - Key news
Johnson and Johnson Services Inc. - Key offerings
Johnson and Johnson Services Inc. - Segment focus
12.11 Merck and Co. Inc.
Merck and Co. Inc. - Overview
Merck and Co. Inc. - Business segments
Merck and Co. Inc. - Key news
Merck and Co. Inc. - Key offerings
Merck and Co. Inc. - Segment focus
12.12 Novartis AG
Novartis AG - Overview
Novartis AG - Business segments
Novartis AG - Key news
Novartis AG - Key offerings
Novartis AG - Segment focus
12.13 Pfizer Inc.
Pfizer Inc. - Overview
Pfizer Inc. - Product / Service
Pfizer Inc. - Key news
Pfizer Inc. - Key offerings
12.14 PharmaMar SA
PharmaMar SA - Overview
PharmaMar SA - Business segments
PharmaMar SA - Key offerings
PharmaMar SA - Segment focus
12.15 Sanofi SA
Sanofi SA - Overview
Sanofi SA - Business segments
Sanofi SA - Key news
Sanofi SA - Key offerings
Sanofi SA - Segment focus
12.16 Takeda Pharmaceutical Co. Ltd.
Takeda Pharmaceutical Co. Ltd. - Overview
Takeda Pharmaceutical Co. Ltd. - Product / Service
Takeda Pharmaceutical Co. Ltd. - Key news
Takeda Pharmaceutical Co. Ltd. - Key offerings
12.17 Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd. - Overview
Teva Pharmaceutical Industries Ltd. - Business segments
Teva Pharmaceutical Industries Ltd. - Key news
Teva Pharmaceutical Industries Ltd. - Key offerings
Teva Pharmaceutical Industries Ltd. - Segment focus
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
13.3 Currency conversion rates for US$
Currency conversion rates for US$
13.4 Research methodology
Research methodology
13.5 Data procurement
Information sources
13.6 Data validation
Data validation
13.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
13.8 Data synthesis
Data synthesis
13.9 360 degree market analysis
360 degree market analysis
13.10 List of abbreviations
List of abbreviations
Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Therapy
Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Company Market Positioning
Exhibits10: Parent Market
Exhibits11: Data Table on - Parent Market
Exhibits12: Market characteristics analysis
Exhibits13: Value Chain Analysis
Exhibits14: Offerings of companies included in the market definition
Exhibits15: Market segments
Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits20: Historic Market Size - Data Table on Global Multiple Myeloma Drugs Market 2018 - 2022 ($ million)
Exhibits21: Historic Market Size - Therapy Segment 2018 - 2022 ($ million)
Exhibits22: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits25: Five forces analysis - Comparison between 2023 and 2028
Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits31: Chart on Market condition - Five forces 2023 and 2028
Exhibits32: Chart on Therapy - Market share 2023-2028 (%)
Exhibits33: Data Table on Therapy - Market share 2023-2028 (%)
Exhibits34: Chart on Comparison by Therapy
Exhibits35: Data Table on Comparison by Therapy
Exhibits36: Chart on Targeted therapy - Market size and forecast 2023-2028 ($ million)
Exhibits37: Data Table on Targeted therapy - Market size and forecast 2023-2028 ($ million)
Exhibits38: Chart on Targeted therapy - Year-over-year growth 2023-2028 (%)
Exhibits39: Data Table on Targeted therapy - Year-over-year growth 2023-2028 (%)
Exhibits40: Chart on Biologic therapy - Market size and forecast 2023-2028 ($ million)
Exhibits41: Data Table on Biologic therapy - Market size and forecast 2023-2028 ($ million)
Exhibits42: Chart on Biologic therapy - Year-over-year growth 2023-2028 (%)
Exhibits43: Data Table on Biologic therapy - Year-over-year growth 2023-2028 (%)
Exhibits44: Chart on Chemotherapy - Market size and forecast 2023-2028 ($ million)
Exhibits45: Data Table on Chemotherapy - Market size and forecast 2023-2028 ($ million)
Exhibits46: Chart on Chemotherapy - Year-over-year growth 2023-2028 (%)
Exhibits47: Data Table on Chemotherapy - Year-over-year growth 2023-2028 (%)
Exhibits48: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibits49: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibits50: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits51: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits52: Market opportunity by Therapy ($ million)
Exhibits53: Data Table on Market opportunity by Therapy ($ million)
Exhibits54: Chart on Distribution Channel - Market share 2023-2028 (%)
Exhibits55: Data Table on Distribution Channel - Market share 2023-2028 (%)
Exhibits56: Chart on Comparison by Distribution Channel
Exhibits57: Data Table on Comparison by Distribution Channel
Exhibits58: Chart on Hospital pharmacy - Market size and forecast 2023-2028 ($ million)
Exhibits59: Data Table on Hospital pharmacy - Market size and forecast 2023-2028 ($ million)
Exhibits60: Chart on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
Exhibits61: Data Table on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
Exhibits62: Chart on Retail pharmacy - Market size and forecast 2023-2028 ($ million)
Exhibits63: Data Table on Retail pharmacy - Market size and forecast 2023-2028 ($ million)
Exhibits64: Chart on Retail pharmacy - Year-over-year growth 2023-2028 (%)
Exhibits65: Data Table on Retail pharmacy - Year-over-year growth 2023-2028 (%)
Exhibits66: Chart on E-pharmacy - Market size and forecast 2023-2028 ($ million)
Exhibits67: Data Table on E-pharmacy - Market size and forecast 2023-2028 ($ million)
Exhibits68: Chart on E-pharmacy - Year-over-year growth 2023-2028 (%)
Exhibits69: Data Table on E-pharmacy - Year-over-year growth 2023-2028 (%)
Exhibits70: Market opportunity by Distribution Channel ($ million)
Exhibits71: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits72: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits73: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits74: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits75: Chart on Geographic comparison
Exhibits76: Data Table on Geographic comparison
Exhibits77: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits78: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits79: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits80: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits81: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits82: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits83: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits84: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits85: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits86: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits87: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits88: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits89: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits90: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits91: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits92: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits93: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits94: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits95: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits96: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits97: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits98: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits99: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits100: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits101: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits102: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits103: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits104: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits105: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits106: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits107: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits108: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits109: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits110: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits111: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits112: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits113: Market opportunity By Geographical Landscape ($ million)
Exhibits114: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits115: Impact of drivers and challenges in 2023 and 2028
Exhibits116: Overview on criticality of inputs and factors of differentiation
Exhibits117: Overview on factors of disruption
Exhibits118: Impact of key risks on business
Exhibits119: Companies covered
Exhibits120: Matrix on companies position and classification
Exhibits121: Abbott Laboratories - Overview
Exhibits122: Abbott Laboratories - Business segments
Exhibits123: Abbott Laboratories - Key news
Exhibits124: Abbott Laboratories - Key offerings
Exhibits125: Abbott Laboratories - Segment focus
Exhibits126: AbbVie Inc. - Overview
Exhibits127: AbbVie Inc. - Product / Service
Exhibits128: AbbVie Inc. - Key news
Exhibits129: AbbVie Inc. - Key offerings
Exhibits130: Amgen Inc. - Overview
Exhibits131: Amgen Inc. - Product / Service
Exhibits132: Amgen Inc. - Key news
Exhibits133: Amgen Inc. - Key offerings
Exhibits134: Bristol Myers Squibb Co. - Overview
Exhibits135: Bristol Myers Squibb Co. - Product / Service
Exhibits136: Bristol Myers Squibb Co. - Key news
Exhibits137: Bristol Myers Squibb Co. - Key offerings
Exhibits138: Daiichi Sankyo Co. Ltd. - Overview
Exhibits139: Daiichi Sankyo Co. Ltd. - Product / Service
Exhibits140: Daiichi Sankyo Co. Ltd. - Key news
Exhibits141: Daiichi Sankyo Co. Ltd. - Key offerings
Exhibits142: F. Hoffmann La Roche Ltd. - Overview
Exhibits143: F. Hoffmann La Roche Ltd. - Business segments
Exhibits144: F. Hoffmann La Roche Ltd. - Key news
Exhibits145: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits146: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits147: GlaxoSmithKline Plc - Overview
Exhibits148: GlaxoSmithKline Plc - Business segments
Exhibits149: GlaxoSmithKline Plc - Key news
Exhibits150: GlaxoSmithKline Plc - Key offerings
Exhibits151: GlaxoSmithKline Plc - Segment focus
Exhibits152: Johnson and Johnson Services Inc. - Overview
Exhibits153: Johnson and Johnson Services Inc. - Business segments
Exhibits154: Johnson and Johnson Services Inc. - Key news
Exhibits155: Johnson and Johnson Services Inc. - Key offerings
Exhibits156: Johnson and Johnson Services Inc. - Segment focus
Exhibits157: Merck and Co. Inc. - Overview
Exhibits158: Merck and Co. Inc. - Business segments
Exhibits159: Merck and Co. Inc. - Key news
Exhibits160: Merck and Co. Inc. - Key offerings
Exhibits161: Merck and Co. Inc. - Segment focus
Exhibits162: Novartis AG - Overview
Exhibits163: Novartis AG - Business segments
Exhibits164: Novartis AG - Key news
Exhibits165: Novartis AG - Key offerings
Exhibits166: Novartis AG - Segment focus
Exhibits167: Pfizer Inc. - Overview
Exhibits168: Pfizer Inc. - Product / Service
Exhibits169: Pfizer Inc. - Key news
Exhibits170: Pfizer Inc. - Key offerings
Exhibits171: PharmaMar SA - Overview
Exhibits172: PharmaMar SA - Business segments
Exhibits173: PharmaMar SA - Key offerings
Exhibits174: PharmaMar SA - Segment focus
Exhibits175: Sanofi SA - Overview
Exhibits176: Sanofi SA - Business segments
Exhibits177: Sanofi SA - Key news
Exhibits178: Sanofi SA - Key offerings
Exhibits179: Sanofi SA - Segment focus
Exhibits180: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits181: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits182: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits183: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits184: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits185: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits186: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits187: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits188: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits189: Inclusions checklist
Exhibits190: Exclusions checklist
Exhibits191: Currency conversion rates for US$
Exhibits192: Research methodology
Exhibits193: Information sources
Exhibits194: Data validation
Exhibits195: Validation techniques employed for market sizing
Exhibits196: Data synthesis
Exhibits197: 360 degree market analysis
Exhibits198: List of abbreviations
